Teva board OKs $3B buyback plan; Merck to pay $24M in Medicaid suit;

@FiercePharma: EU reins in exports of lethal-injection drugs, barring sale in countries still using death penalty. News | Follow @FiercePharma

> Teva Pharmaceutical Industries ($TEVA) says its board approved a $3 billion share buyback plan, or about 7.5% of its outstanding shares. News

> Merck ($MRK) has agreed to pay Massachusetts $24 million to settle a Medicaid fraud lawsuit. Story

> India's Zydus Cadila bought Mumbai-based antibiotics maker Biochem in a bid to grow its business in finished drugs. Item

> Akzo Novel was cited by FDA for failures at its active pharmaceutical ingredient plant in Los Reyes La Paz, Mexico. Article

> Marsh Supermarkets won a $19.5 million judgment against Roche over a sublease deal gone bad. Story

> The ringleader of a Houston-based smuggling operation was ordered to pay $140,000 in restitution to Eli Lilly ($LLY) and Pfizer ($PFE) for selling counterfeit versions of ED drugs. Report

Biotech News

@FierceBiotech: Tiny robots may be next big drug-delivery thing. News | Follow @FierceBiotech

@JohnCFierce: A struggling AstraZeneca commits $140M to cancer pact as it inks back-to-back deals. Story | Follow @JohnCFierce

@RyanMFierce: Takeda doesn't say how many jobs will be impacted in the move to consolidate in San Diego. Release | Follow @RyanMFierce

@MarkHFierce: Perosphere debuts! It has connections with Brown, Harvard and MIT, among others. Article | Follow @MarkHFierce

> AZ commits $140M to cancer pact as it inks back-to-back deals. News

> Takeda picks up a pair of cancer drugs in $310M Intellikine buyout. More

Medical Device News

> Philips, Steris to add 200 jobs in Ohio. Article

> Report: GE plans to add 200 engineers in China. Story

Drug Delivery News

> Pfizer to employ Antares drug-delivery tech for mystery product. News

> Perosphere launches with Brown, Harvard and MIT connections. Article

> Say it with lollipops to treat oral thrush. Item

> Eli Lilly advances drug delivery tech deals with Starpharma, Arecor. Story

Biomarkers News

> Biomarker predicts tamoxifen breast cancer response. More

> Urinary serotonin may be key to test for depression. Story

And Finally... Medieval knights may have suffered from PTSD, researcher says. Report

Suggested Articles

The FDA accused Pennsylvania's KVK-Tech of failing to install proper cleaning protocols at its oral solid-dose manufacturing plant in Newtown.

Today, AmerisourceBergen kicked off its first-ever ThinkLive Trade virtual event, a three-day online summit geared toward manufacturers.

With interim data for its COVID-19 vaccine still in the works, Pfizer is holding on to hope that it can still roll the shot out this year in the U.S.